The Use of Botulinum Toxin Type A in the Upper Face

Facial Plastic Surgery Clinics of North America

Volumn 14, Issue 3, 2006, Pages 253-260

  Carruthers, Jean ^a   Carruthers, Alastair ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; CBTX A; LINURASE; NEURONOX; PURETOX; RELOXIN; UNCLASSIFIED DRUG;

DRUG USE; ESTHETICS; EXPERIMENTAL THERAPY; FLU LIKE SYNDROME; HEADACHE; HUMAN; INJECTION; INJECTION SITE CONTUSION; INJECTION SITE PAIN; INJECTION SITE SWELLING; PATIENT CARE; PATIENT EDUCATION; REVIEW; RHYTIDOPLASTY;

BOTULINUM TOXIN TYPE A; COSMETIC TECHNIQUES; EYEBROWS; FACIAL MUSCLES; HUMANS; LASERS; NEUROMUSCULAR AGENTS; REJUVENATION; RHYTIDOPLASTY;

EID: 33747058439     PISSN: 10647406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fsc.2006.04.002     Document Type: Review

References (45)

1. Scott A.B., and Collins C.C. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 12 (1973) 924-927
2. Schantz E.J. Botulinum toxin: the story of its development for the treatment of human disease. Perspect Biol Med 40 (1997) 317-327
3. Scott A.B. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87 (1980) 1044-1049
4. Carruthers J., and Stubbs H.A. Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid ectropion. Can J Neurol Sci 14 (1987) 42-45
5. Jankovic J., and Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 40 (1990) 277-280
6. Glogau R. Botulinum A neurotoxin for axillary hyperhidrosis: no sweat Botox. Dermatol Surg 24 (1998) 817-819
7. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 85 (2000) 101-105
8. Blumenfeld A.M., Dodick D.W., and Silberstein S.D. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders. Dermatol Clin 22 (2004) 167-175
9. Carruthers J.D.A., and Carruthers J.A. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 18 (1992) 17-21
10. Borodic G.E. Botulinum A toxin for (expressionistic) ptosis overcorrection after frontalis sling. Ophthal Plast Reconstr Surg 8 (1992) 137-142
11. Blitzer A., Brin M.F., Keen M.S., et al. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg 9 (1993) 1018-1022
12. Carruthers J.A., Lowe N.J., Menter M.A., et al. A multicentre, double-blind, randomized, placebo-controlled study of efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 46 (2002) 840-849
13. BOTOX Cosmetic [package insert]. Allergan, Irvine, California, 2002.
14. Klein A.W. Dilution and storage of botulinum toxin. Dermatol Surg 24 (1998) 1179-1180
15. Hexsel D.M., de Almeida A.T., Rutowitsch M., et al. Multicenter, double-blind study of the efficacy of injections with botulinum toxin type A reconstituted in 6 consecutive weeks. Dermatol Surg 29 (2003) 523-529
16. Huang W., Foster J.A., and Rogachefsky A.S. Pharmacology of botulinum toxin. J Am Acad Dermatol 43 (2000) 249-259
17. Alam M., Dover J.S., and Arndt K.A. Pain associated with injection of botulinum A exotoxin reconstituted using isotonic sodium chloride with and without preservative: a double-blind, randomized controlled trial. Arch Dermatol 138 (2002) 510-514
18. Carruthers J., Fagien S., Matarasso S.L., et al. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 114 (2004) 1S-22S
19. Carruthers A., and Carruthers J. Botulinum toxin type A: history and current cosmetic use in the upper face. Semin Cutan Med Surg 20 (2001) 71-84
20. Guyuron B., and Huddleston S. Aesthetic indications for botulinum toxin. Plast Reconstr Surg 93 (1999) 913-918
21. Klein A.W. Complications, adverse reactions, and insights with the use of botulinum toxin. Dermatol Surg 29 (2003) 549-556
22. Hsu T.S.J., Dover J.S., and Arndt K.A. Effect of volume and concentration on the diffusion of botulinum exotoxin A. Arch Dermatol 140 (2004) 1351-1354
23. Hankins C.L., Strimling R., and Rogers G.S. Botulinum A toxin for glabellar wrinkles. Dermatol Surg 24 (1998) 1181-1183
24. Carruthers A, Carruthers J, Cohen J. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter? In press 2006.
25. Carruthers A, Dover JS, Carruthers JDA, et al. A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides. In press 2006.
26. Carruthers A., Carruthers J., and Said S. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females. Dermatol Surg 31 (2005) 414-422
27. Carruthers A., and Carruthers J. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatol Surg 31 (2005) 1297-1303
28. Ahn M.S., Catten M., and Maas C.S. Temporal brow lift using botulinum toxin A. Plast Reconstruct Surg 105 (2000) 1129-1135
29. Huang W., Rogachefsky A.S., and Foster J.A. Brow lift with botulinum toxin. Dermatol Surg 26 (2000) 55-60
30. Huilgol S.C., Carruthers A., and Carruthers J.D.A. Raising eyebrows with botulinum toxin. Dermatol Surg 25 (2000) 373-376
31. Carruthers A, Carruthers J, Said S. Botulinum toxin type A (BTX-A) in the treatment of glabellar rhytids: an objective analysis of treatment response. Presented at the Annual Meeting of the American Academy of Dermatology. New Orleans, February 22-27, 2002.
32. Carruthers A, Carruthers J. Eyebrow height after botulinum toxin type A to the glabella. In press 2006.
33. Carruthers J., and Carruthers A. BOTOX use in the mid and lower face and neck. Semin Cutan Med Surg 20 (2001) 85-92
34. Flynn T.C., Carruthers J.A., and Carruthers J.A. Botulinum A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg 27 (2001) 703-708
35. Fagien S. Botox for the treatment of dynamic and hyperkinetic facial lines and furrows: adjunctive use in facial aesthetic surgery. Plast Reconstr Surg 112 (2003) 40S-52S
36. Carruthers J., Carruthers A., and Maberley D. Deep resting glabellar rhytides respond to BTX-A and Hylan B. Dermatol Surg 29 (2003) 539-544
37. Carruthers J., and Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative BTX-A. Dermatol Surg 29 (2003) 802-809
38. Patel M.P., Talmor M., and Nolan W.B. Botox and collagen for glabellar furrows: advantages of combination therapy. Ann Plast Surg 52 (2004) 442-447
39. 2 laser resurfacing. Dermatol Surg 25 (1999) 259-261
40. Zimbler M.S., Holds J.B., Kokoska M.S., et al. Effect of botulinum toxin pretreatment on laser resurfacing results: a prospective, randomized, blinded trial. Arch Facial Plast Surg 3 (2001) 165-169
41. Lowe N, Lask G, Yamauchi P, et al. Botulinum toxin type A (BTX-A) and ablative laser resurfacing (erbium: YAG): a comparison of efficacy and safety of combination therapy vs. ablative laser resurfacing alone for the treatment of crow's feet. Presented at the American Academy of Dermatology 2002 Summer Meeting. New York, July 31-August 4, 2002.
42. Carruthers J., Carruthers A., and Zelichowska A. The power of combined therapies: Botox and ablative facial laser resurfacing. Am J Cosmetic Surg 17 (2000) 129-131
43. Carruthers J., and Carruthers A. The effect of full-face broadband light treatments alone and in combination with bilateral crow's feet botulinum toxin type A chemodenervation. Dermatol Surg 30 (2004) 355-366
44. Cote T.R., Mohan A.K., Polder J.A., et al. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 53 (2005) 407-415
45. Carruthers A., Carruthers J. Long-term safety of cosmetic botulinum toxin type A: a review. In press, 2006.